持续输注Cefiderocol在一个病情危急的病人持续有毒血液过
Julia E Möhlmann1, Matthijs van Luin1, Esther V Uijtendaal1
1Department of Clinical Pharmacy, University Medical Centre Utrecht, University Utrecht, Utrecht, The Netherlands.
持续输注 (CI) 赛菲德罗科尔在患有多药耐药性Pseudomonas aeruginosa的重症患者中显示出足够的药物暴露,该患者正在接受持续毒静脉血过 (CVVH). 这支持CI作为复杂患者群体中Cefiderocol的可行的施用方法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 塞菲德罗科尔是一种用于困难的格兰氏阴性感染的宽谱类药物,通常用间歇性输液给予.
- 连续输注 (CI) 可以通过维持未结合度超过最小抑制度 (MIC) 来优化 cefiderocol 的治疗标.
- 在连续输注期间存在关于赛菲德罗科尔药理动学的有限数据,特别是在需要替代疗法的危急病患者中.
更多相关视频
09:57A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
09:17Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
相关概念视频
Continuous Renal Replacement Therapy
One-Compartment Model: IV Infusion
The one-compartment model for IV infusion uses mathematical equations to describe the rate of change in drug quantity in the body. At steady-state or infusion equilibrium, the drug input...
Hemodialysis III: Nursing Management
Steady State Concentration
Most drugs are administered in repeated doses at fixed intervals or through continuous...
Hemodialysis II: Procedure and Complications
Venous Thrombosis III: Interprofessional Care
